ProQR Therapeutics (PRQR) Receivables - Other (2021 - 2024)
Historic Receivables - Other for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $892277.1.
- ProQR Therapeutics' Receivables - Other rose 1131.55% to $892277.1 in Q4 2024 from the same period last year, while for Dec 2024 it was $892277.1, marking a year-over-year increase of 1131.55%. This contributed to the annual value of $903752.4 for FY2024, which is 1214.48% up from last year.
- As of Q4 2024, ProQR Therapeutics' Receivables - Other stood at $892277.1, which was up 1131.55% from $801575.3 recorded in Q4 2023.
- In the past 5 years, ProQR Therapeutics' Receivables - Other registered a high of $892277.1 during Q4 2024, and its lowest value of $306584.3 during Q4 2021.
- Over the past 4 years, ProQR Therapeutics' median Receivables - Other value was $592084.0 (recorded in 2022), while the average stood at $595757.3.
- Per our database at Business Quant, ProQR Therapeutics' Receivables - Other skyrocketed by 10951.14% in 2023 and then skyrocketed by 1131.55% in 2024.
- Quarter analysis of 4 years shows ProQR Therapeutics' Receivables - Other stood at $306584.3 in 2021, then rose by 24.79% to $382592.7 in 2022, then skyrocketed by 109.51% to $801575.3 in 2023, then grew by 11.32% to $892277.1 in 2024.
- Its Receivables - Other was $892277.1 in Q4 2024, compared to $801575.3 in Q4 2023 and $382592.7 in Q4 2022.